ANZUPGO (LEO Pharma Pty Ltd)
Product name
ANZUPGO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
124 (255 working days)
Active ingredients
delgocitinib
Registration type
NCE/ NBE
Indication
ANZUPGO is indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults for whom topical corticosteroids are inadequate or inappropriate.